yeah could be, good point, a buyback basically provides a floor price for their shares and sufficient buying volume, as opposed to selling/drip feeding onto market with a relatively low liquidity register where large volumes can move it south too much and lose significant value.
I never thought of that - bit of a wink wink we'll sort you out via a buyback and means we can remove that acquisition scrip from the balance sheet
- Forums
- ASX - By Stock
- Ann: On-Market Buyback and Appendix 3C
yeah could be, good point, a buyback basically provides a floor...
Featured News
Add DNA (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.35M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125243 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 118554 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125243 | 0.027 |
6 | 435983 | 0.026 |
1 | 20000 | 0.025 |
1 | 320000 | 0.024 |
1 | 100000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 118554 | 2 |
0.029 | 112795 | 3 |
0.030 | 381409 | 4 |
0.032 | 500000 | 1 |
0.033 | 305891 | 1 |
Last trade - 10.39am 18/11/2024 (20 minute delay) ? |
Featured News
DNA (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online